Research Article
Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain
Table 1
Estimated medical resource utilization over 6 months per level of disease activity, excluding biological drug costs (in Euros).
| | RS (DAS28 < 2.6) | LDAS (DAS28 ≤ 3.2) | MHDAS (DAS28 > 3.2) | | Min | Mean | Max | Min | Mean | Max | Min | Mean | Max |
| | Rheumatologist visits | 40.8 | — | 290 | | 81.67 | | 122.5 | | 870 | | Orthopedist visits | — | — | — | — | — | — | — | 40.8 | — | | Rehabilitation specialist visits | — | — | — | — | — | — | — | 40.8 | — | | Other specialist visits | — | — | — | — | — | — | — | 10.2 | — | | GP visits | — | — | — | — | 28.2 | — | 28.2 | — | 250 | | Lab (standard package) | 32.5 | — | 229.2 | — | 229.2 | — | 343.8 | — | 195.4 | | X-Ray Hands/Feet | — | — | — | — | — | — | 4 | — | 18 | | MRI | — | — | — | — | — | — | — | 290.2 | — | | Hospital | — | — | — | — | — | — | — | 1754.5 | — | | Physio (#days) | — | — | — | — | — | — | 449.7 | — | 3979 | | Surgery Knee | — | — | — | — | — | — | — | 590.4 | — | | Surgery Hands | — | — | — | — | — | — | — | 94.62 | — | | Surgery Feet | — | — | — | — | — | — | — | 109.8 | — | | Medical transportation* | — | — | — | — | — | — | 212.4 | — | 529.6 | | Nursing | — | — | — | 0 | — | 23.6 | 10 | — | 70.9 |
|
|
RS: remission state.
LDAS: low disease activity state.
MHDAS: moderate to high disease activity state.
DAS: disease activity score.
*Transportation to hospital or clinic.
|
